APA (7th ed.) Citation

Alarcan, H., Bruno, C., Emond, P., Raoul, C., Vourc'h, P., Corcia, P., . . . Leigh, P. N. (2024). Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis. Annals of the New York Academy of Sciences, 1536(1), 82. https://doi.org/10.1111/nyas.15147

Chicago Style (17th ed.) Citation

Alarcan, Hugo, et al. "Pharmacometabolomics Applied to Low‐dose Interleukin‐2 Treatment in Amyotrophic Lateral Sclerosis." Annals of the New York Academy of Sciences 1536, no. 1 (2024): 82. https://doi.org/10.1111/nyas.15147.

MLA (9th ed.) Citation

Alarcan, Hugo, et al. "Pharmacometabolomics Applied to Low‐dose Interleukin‐2 Treatment in Amyotrophic Lateral Sclerosis." Annals of the New York Academy of Sciences, vol. 1536, no. 1, 2024, p. 82, https://doi.org/10.1111/nyas.15147.